Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GUCY1B2 | O75343 | 19/20 | 0.48 |
| ▸ | GUCY1A2 | P33402 | 19/20 | 0.48 |
| ▸ | GUCY1A1 | Q02108 | 19/20 | 0.48 |
| ▸ | GUCY1B1 | Q02153 | 19/20 | 0.48 |
| ▸ | CD274 | Q9NZQ7 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19110568 | 0.97 | GUCY1B2 (0.47) | GUCY1B2GUCY1A2GUCY1A1GUCY1B1CD274 | |
| SCHEMBL14709443 | 0.93 | GUCY1B2 (0.49) | GUCY1B2GUCY1A2GUCY1A1GUCY1B1CD274 | |
| SCHEMBL14697119 | 0.93 | GUCY1B2 (0.53) | GUCY1B2GUCY1A2GUCY1A1GUCY1B1 | |
| SCHEMBL14709595 | 0.93 | GUCY1B2 (0.50) | GUCY1B2GUCY1A2GUCY1A1GUCY1B1CD274 | |
| SCHEMBL14709646 | 0.93 | CD274 (0.49) | GUCY1B2GUCY1A2GUCY1A1GUCY1B1CD274 | |
| SCHEMBL14709477 | 0.91 | GUCY1B2 (0.47) | GUCY1B2GUCY1A2GUCY1A1GUCY1B1CD274 | |
| SCHEMBL14709676 | 0.91 | GUCY1B2 (0.48) | GUCY1B2GUCY1A2GUCY1A1GUCY1B1CD274 | |
| SCHEMBL19111635 | 0.91 | GUCY1B2 (0.47) | GUCY1B2GUCY1A2GUCY1A1GUCY1B1CD274 | |
| SCHEMBL19111619 | 0.91 | GUCY1B2 (0.47) | GUCY1B2GUCY1A2GUCY1A1GUCY1B1CD274 | |
| SCHEMBL19111655 | 0.91 | GUCY1B2 (0.47) | GUCY1B2GUCY1A2GUCY1A1GUCY1B1CD274 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2766360-B1 | SOLUBLE GUANYLATE CYCLASE ACTIVATORS | BOEHRINGER INGELHEIM INT (DE) | 2017-07-12 | — | — | EP | disclosed |